Search research articles
Contact Us
Filters
Showing results (191-200 of 237) with videos related to
Page
of 24
Sort By:
Disease Models & Mechanisms
|
November 24, 2018
Semiology, clustering, periodicity and natural history of seizures in an experimental occipital cortical epilepsy model
Bao-Luen Chang, Marco Leite, Albert Snowball, et al.
Science (New York, N.Y.)
|
March 29, 2008
Electric fields due to synaptic currents sharpen excitatory transmission
Sergiy Sylantyev, Leonid P Savtchenko, Yin-Ping Niu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 15, 2021
Impaired Pre-Motor Circuit Activity and Movement in a Drosophila Model of KCNMA1-Linked Dyskinesia
Patrick Kratschmer, Simon A Lowe, Edgar Buhl, et al.
Brain : a Journal of Neurology
|
October 16, 2012
In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission
Susan E Tomlinson, Hugh Bostock, Bronwyn Grinton, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
June 14, 2008
Synapsin- and actin-dependent frequency enhancement in mouse hippocampal mossy fiber synapses
Simen G Owe, Vidar Jensen, Emma Evergren, et al.
Brain : a Journal of Neurology
|
October 9, 2019
Glycine receptor autoantibodies disrupt inhibitory neurotransmission
Sarah J Crisp, Christine L Dixon, Leslie Jacobson, et al.
Science Translational Medicine
|
November 14, 2012
Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy
Robert C Wykes, Joost H Heeroma, Laura Mantoan, et al.
Critical Care Medicine
|
December 18, 2009
Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit
Gerard Davies, Sarosh R Irani, Cordelia Coltart, et al.
Signal Transduction and Targeted Therapy
|
July 2, 2026
Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent
Steven O Devenish, Sahil D Patel, Laura V Ussingkær, et al.
BMJ Neurology Open
|
June 3, 2021
Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis
Kushan Karunaratne, Dariush Ahrabian, Bernadette Monoghan, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 237) with videos related to
Sort By:
Page
of 24
Disease Models & Mechanisms
|
November 24, 2018
Semiology, clustering, periodicity and natural history of seizures in an experimental occipital cortical epilepsy model
Bao-Luen Chang, Marco Leite, Albert Snowball, et al.
Science (New York, N.Y.)
|
March 29, 2008
Electric fields due to synaptic currents sharpen excitatory transmission
Sergiy Sylantyev, Leonid P Savtchenko, Yin-Ping Niu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 15, 2021
Impaired Pre-Motor Circuit Activity and Movement in a Drosophila Model of KCNMA1-Linked Dyskinesia
Patrick Kratschmer, Simon A Lowe, Edgar Buhl, et al.
Brain : a Journal of Neurology
|
October 16, 2012
In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission
Susan E Tomlinson, Hugh Bostock, Bronwyn Grinton, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
June 14, 2008
Synapsin- and actin-dependent frequency enhancement in mouse hippocampal mossy fiber synapses
Simen G Owe, Vidar Jensen, Emma Evergren, et al.
Brain : a Journal of Neurology
|
October 9, 2019
Glycine receptor autoantibodies disrupt inhibitory neurotransmission
Sarah J Crisp, Christine L Dixon, Leslie Jacobson, et al.
Science Translational Medicine
|
November 14, 2012
Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy
Robert C Wykes, Joost H Heeroma, Laura Mantoan, et al.
Critical Care Medicine
|
December 18, 2009
Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit
Gerard Davies, Sarosh R Irani, Cordelia Coltart, et al.
Signal Transduction and Targeted Therapy
|
July 2, 2026
Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent
Steven O Devenish, Sahil D Patel, Laura V Ussingkær, et al.
BMJ Neurology Open
|
June 3, 2021
Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis
Kushan Karunaratne, Dariush Ahrabian, Bernadette Monoghan, et al.
Page
of 24